Eicosanoid post-mortem induction in kidney tissue is prevented by microwave irradiation

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 5, 2013, Pages 313-318

  Brose, Stephen A ^a   Golovko, Mikhail Y ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Eicosanoids; Kidney; Mass spectrometry; Microwave irradiation; Prostaglandins

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; INDOMETACIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MICROWAVE IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EICOSANOIDS; KIDNEY; MASS SPECTROMETRY; MICROWAVE IRRADIATION; PROSTAGLANDINS;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ARACHIDONIC ACID; AUTOPSY; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HYDROXYEICOSATETRAENOIC ACIDS; INDOMETHACIN; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MICE; MICE, INBRED C57BL; MICROWAVES; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THROMBOXANE B2; TISSUE FIXATION;

EID: 84886947367     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.09.005     Document Type: Article

References (36)

1. Quilley J., Chen Y.-J. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 2003, 42:837-843.
2. Harris R.C. Cyclooxygenase-2 in the kidney. J. Am. Soc. Nephrol. 2000, 11:2387-2394.
3. Askari B., Bell-Quilley C.P., Fulton D., Quilley J., McGiff J.C. Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia. J. Pharmacol. Exp. Ther. 1997, 282:101-107.
4. Guo Q.-Y., Miao L.-N., Li B., Ma F.-Z., Liu N., Cai L., Xu Z.-G. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats. Am. J. Physiol.-Endocrinol. Metab. 2011, 300:E708-E716.
5. Xu Z.-G., Yuan H., Lanting L., Li S.-L., Wang M., Shanmugam N., Kato M., Adler S.G., Reddy M.A., Natarajan R. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. J. Am. Soc. Nephrol. 2008, 19:559-569.
6. Golovko M.Y., Murphy E.J. Brain prostaglandin formation is increased by à-synuclein gene-ablation during global ischemia,. Neurosci. Lett. 2008, 432:243-247.
7. Golovko M.Y., Murphy E.J. An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction. J. Lipid Res. 2008, 49:893-902.
8. Anton R.F., Wallis C., Randall C.L. In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins 1983, 26:421-429.
9. Galli C., Racagni G., Lands W.E.M., Smith W.L. Use of microwave techniques to inactivate brain enzymes rapidly. Methods in Enzymology 1982, 635-642. Academic Press, New York. S.P. Colowick, N.O. Kaplan (Eds.).
10. Farias S.E., Basselin M., Chang L., Heidenreich K.A., Rapoport S.I., Murphy R.C. Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J. Lipid Res. 2008, 49:1990-2000.
11. Murphy E.J. Brain fixation for analysis of brain lipid-mediators of signal transduction and brain eicosanoids requires head-focused microwave irradiation: an historical perspective. Prostaglandins Other Lipid Mediat. 2010, 91:63-67.
12. Whinnery M.A., Shaw J.O., Beck N. Thromboxane B2 and prostaglandin E2 in the rat kidney with unilateral ureteral obstruction. Am. J. Physiol.-Renal Physiol. 1982, 242:F220-F225.
13. Turull À., Queralt J. Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: effects of flosulide. Prostaglandins Other Lipid Mediat. 2001, 66:27-37.
14. Yanagisawa H., Moridaira K., Nodera M., Wada O. Ureteral obstruction enhances eicosanoid production in cortical and medullary tubules of rat kidneys. Kidney Blood Press. Res. 1997, 20:398-405.
15. Nahorski S.R., Hunt N.H., Rogers K.J., Jones P., Martin T.J. Studies in vivo on the effects of parathyroid hormone upon kidney cyclic adenosine 3',5'monophosphate content using rapid tissue fixation by microwave irradiation. Horm. Metab. Res. 1976, 8:311-316.
16. Brose S.A., Thuen B.T., Golovko M.Y. LC/MS/MS method for analysis of E2 series prostaglandins and isoprostanes. J. Lipid Res. 2011, 52:850-859.
17. Raatz S.K., Golovko M.Y., Brose S.A., Rosenberger T.A., Burr G.S., Wolters W.R., Picklo M.J. Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar). J. Agric. Food Chem. 2011, 59:11278-11286.
18. Brose S., Baker A., Golovko M. A fast one-step extraction and UPLC-MS/MS analysis for E2/D2 Series prostaglandins and isoprostanes. Lipids 2013, 48:411-419.
19. Brose S.A., Golovko M.Y. A rapid oxygen exchange on prostaglandins in plasma represents plasma esterase activity that is inhibited by diethylumbelliferyl phosphate with high affinity. Rapid Commun. Mass Spectrom. 2012, 26:2472-2476.
20. Nørregaard R., Jensen B.L., Topcu S.O., Wang G., Schweer H., Nielsen S., Frøkiær J. Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue. Am. J. Physiol.-Regul., Integrative Comp. Physiol. 2010, 298:R1017-R1025.
21. Bonvalet J.P., Pradelles P., Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am. J. Physiol.-Renal Physiol- 1987, 253:F377-F387.
22. Qi Z., Cai H., Morrow J.D., Breyer M.D. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 2006, 48:323-328.
23. Fukuzaki A., Morrissey J., Klahr S. Role of glomerular eicosanoid production in the obstructed kidney. Int. Urol. Nephrol. 1993, 25:525-531.
24. Câmpean V., Theilig F., Paliege A., Breyer M., Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am. J. Physiol.-Renal Physiol. 2003, 285:F19-F32.
25. Belton O., Byrne D., Kearney D., Leahy A., Fitzgerald D.J. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000, 102:840-845.
26. Gohara A., Eltaki N., Sabry D., Murtagh D., Jankun J., Selman S.H., Skrzypczak-Jankun E. Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in cancer. Oncol. Rep. 2012, 28:1275-1282.
27. Bazan N.G. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta 1970, 218:1-10.
28. Bazan N.G., Aveldao de Caldironi M.I., Rodriguez de Turco E.B. Rapid release of free arachidonic acid in the central nervous system due to stimulation. Prog. Lipid Res. 1981, 20:523-529.
29. Bosisio E., Galli C., Galli G., Nicosia S., Spagnuolo C., Tosi L. Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex cerebellum. Prostaglandins 1976, 11:773-781.
30. Maoz D., Lee H.J., Deutsch J., Rapoport S.I., Bazinet R.P. Immediate no-flow ischemia decreases rat heart nonesterified fatty acid and increases acyl-CoA species concentrations. Lipids 2005, 40:1149-1154.
31. Ikeda M., Yoshida S., Busto R., Santiso M., Ginsberg M.D. Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia. J. Neurochem. 1986, 47:123-132.
32. Lin T.N., Liu T.H., Xu J., Hsu C.Y., Sun G.Y. Brain polyphosphoinositide metabolism during focal ischemia in rat cortex. Stroke 1991, 22:495-498.
33. Yoshida S., Ideda M., Busto R., Santiso M., Martinez E., Ginsberg M.D. Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J. Neurochem. 1986, 47:744-757.
34. Ruidera E., Irazu C.E., Rajagopalan P.R., Orak J.K., Fitts C.T., Singh I. Fatty acid metabolism in renal ischemia. Lipids 1988, 23:882-884.
35. Lachowiez R.M., Hammoud N.M., Teibel J.L., Dix J.A. Phospholipase activation, free fatty acids and the proton permeability of a biological membrane. FEBS Lett. 1988, 234:195-198.
36. Frölich S., Olliges A., Kern N., Schreiber Y., Narumiya S., Nüsing R.M. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition. Am. J. Physiol.-Renal Physiol. 2012, 303:F209-F219.